EurekaMag.com logo
+ Translate

Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia


, : Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia. American Journal of Cardiology 62(4): 229-233

The electrophysiologic effects of intravenous flecianide were evaluated in 16 patients aged 9 .+-. 4 years: 15 with recurrent paroxysmal supraventricular tachcardia (SVT) and 1 with overt accessory pathway and history of syncope. Eleven patients had an accessory pathway; it was concealed in 2, overt in 9 and in 10 of these patients an orthodromic atrioventricular reentrant tachycardia was induced. Five patients without accessory pathway had an atrioventricular nodal reentrant tachycardia. After intravenous flecaindie (1.5 mg/kg) the effective refractory period of the atrium and ventricle increased significantly; the anterograde and retrograde effective refractory periods of the atrioventricular node did not. Flecainide blocked retrograde conduction in the accessory pathway in 4 patients (effective refractory period 245 .+-. 41 ms) and antergrade conduction in 8 of 9 patients (effective refractory period 284 .+-. 57 ms). The mean cycle length of orthodromic reciprocating tachcardia and atrioventricular nodal reentrant tachycardia increased significantly. After flecainide tachycardia was noninducible in 6 patiens with orthodromic reciprocating tachycardia and in 1 with atrioventricular nodal reentrant tachycardia. It was inducible but nonsustained (.ltoreq.30 seconds) in 1 patients with orthodromic reciprocating tachycardia and in 3 with atrioventricular nodal reentrant tachycardia. Fifteen patients continued oral flecainide treatment for 19 .+-. 11 months. Tachycardia recurred in 3 of 4 patients whose arrhythmia was still inducible and sustained after intravnous flecainide, and in 1 of 11 patients in whom tachycardia was noninducible (7 patients) or inducible but nonsustained (4 patients). During long-term administration in 11 patients, flecainide plasma levels, 2 to 3 hours after morning dose, ranged from 254 to 584 .mu.g/liter (370 .+-. 130). These data suggest that flecainide is a promising drug for short- and long-term therapy of SVT in children.

Accession: 005349274

PMID: 3135739

DOI: 10.1016/0002-9149(88)90217-2

Download PDF Full Text: Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Musto B.; D'onofrio A.; Cavallaro C.; Musto A.; Violini R., 1987: Electrophysiologic effects and clinical efficacy of flecainide f in children with recurrent paroxysmal supraventricular tachycardia pst. European Heart Journal 8(ABSTR SUPPL 2): 194

Musto B.; D'onofrio A.; Cavallaro C.; Musto A.; Della Gatta O.; Marsico F., 1987: Electrophysiologic effects and clinical efficacy of flecainide in pediatric patients with recurrent paroxysmal supraventricular tachycardia. The electrophysiologic effects of intravenous (i.v.) flecainide were evaluated in 13 patients (pts) with recurrent paroxysmal supraventricular tachycardia (PSVT): 6 pts had an overt accessory pathway, 2 a concealed anomalous pathway and 5 had an i...

Hoff P.I.; Tronstad A.; Oie B.; Ohm O J., 1988: Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia. The antiarrhythmic effects of flecaininde acetate were evaluated in 9 patients with paroxysmal atrioventricular(AV) nodal tachycardia and 17 patients with AV tachycardia. An electrophysiologic study was performed before and after intravenous fleca...

Musto B.; D'onofrio A.; Cavallaro C.; Musto A.; Violini R., 1987: Electrophysiologic effects and clinical efficacy of propafenone p in children with recurrent paroxysmal supraventricular tachycardia pst. European Heart Journal 8(ABSTR SUPPL 2): 97

Gambhir, D.S.; Bhargava, M.; Arora, R.; Khalilullah, M., 1995: Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia. Flecainide is a class IC antiarrhythmic agent with a controversial role in the treatment of ventricular arrhythmias following myocardial infarction after the publication of the Cardiac Arrhythmia Suppression Trial (CAST). To assess its utility in...

Musto, B.; D'Onofrio, A.; Cavallaro, C.; Musto, A., 1988: Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia. Twenty-four patients aged 10.1 .+-. 4.5 (mean .+-. SD) years with recurrent paroxysmal supraventricular tachycardia underwent an electrophysiological study. Eleven patients had an overt and seven had a concealed accessory connection; six patients...

Musto, B.; D'Onofrio, A.; Cavallaro, C.; Musto, A.; Della Gatta, O.; Marsico, F., 1987: Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia. The electrophysiologic effects of intravenous (i.v.) flecainide were evaluated in 13 patients (pts) with recurrent paroxysmal supraventricular tachycardia (PSVT): 6 pts had an overt accessory pathway, 2 a concealed anomalous pathway and 5 had an i...

Pritchett, E.L.; DaTorre, S.D.; Platt, M.L.; McCarville, S.E.; Hougham, A.J., 1991: Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group. The dose-response relations for efficacy and tolerance of the antiarrhythmic drug flecainide acetate were studied in 28 patients with paroxysmal supraventricular tachycardia (Group 1) and 45 patients with paroxysmal atrial fibrillation or flutter...

Musto, B.; D'Onofrio, A.; Musto, A.; Cavallaro, C.; Marsico, F., 1986: Electrophysiologic effects and clinical efficacy of propafenone in pediatric patients with paroxysmal supraventricular reentrant tachycardia. Twenty patients (pts) with recurrent paroxysmal supraventricular tachycardia (PSVT), 12 female and 8 male, aged 9.8 +/- 4.7 years, underwent an electrophysiologic study (EPS) in order to assess the effects of propafenone (Pf) administered intraven...

Henthorn, R.W.; Waldo, A.L.; Anderson, J.L.; Gilbert, E.M.; Alpert, B.L.; Bhandari, A.K.; Hawkinson, R.W.; Pritchett, E.L., 1991: Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group. Oral flecainide acetate was administered to 34 patients with documented symptomatic paroxysmal supraventricular tachycardia (PSVT) with a double-blind, placebo-controlled, 8-week crossover trial design. PSVT was defined as a regular tachycardia of...